(Q35553266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Schizophrenia and weight management: a systematic review of interventions to control weight (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Andrew Soundy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

K Lloyd

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

324-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531752%20AND%20SRC:MED&resulttype=core&format=json

Weight gain from novel antipsychotic drugs: need for action

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

The poor physical health of people with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Orlistat in the treatment of psychopharmacologically induced weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

INTENSIVE TREATMENT OF PSYCHOTIC BEHAVIOUR BY STIMULUS SATIATION AND FOOD REINFORCEMENT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Rapid Treatment of Gross Obesity by Operant Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Weight reduction in a chronic schizophrenic by means of operant conditioning procedures: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Extreme weight gain in a youth with schizophrenia: risk/benefit considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Metformin for weight loss in pediatric patients taking psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Effect of amantadine on weight gain during olanzapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Interventions for Weight Gain in Adults Treated With Novel Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

A program for treating olanzapine-related weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Cognitive behavior therapy for weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Management of overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Mental health nursing and the promotion of physical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Treatment of obesity: need to focus on high risk abdominally obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Waist circumference as a measure for indicating need for weight management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Physical health of people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

Exercise as an adjunct treatment for schizophrenia: A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

The unhealthy lifestyle of people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Prevalence of obesity in patients receiving depot antipsychotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Improving the physical health of patients with schizophrenia: therapeutic nihilism or realism?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Options for pharmacological management of obesity in patients treated with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Dexfenfluramine in psychotic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

A study of weight reducing diets in psychiatric in-patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Metformin in obesity associated with antipsychotic drug administration: a pilot study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Behavior modification of overeating in a psychiatric population.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2003.00218.X

7 January 2021